• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氘标记抗糖尿病查耳酮的连续流合成:炔酮核心选择性氘代的研究

Continuous-Flow Synthesis of Deuterium-Labeled Antidiabetic Chalcones: Studies towards the Selective Deuteration of the Alkynone Core.

作者信息

Ötvös Sándor B, Hsieh Chi-Ting, Wu Yang-Chang, Li Jih-Heng, Chang Fang-Rong, Fülöp Ferenc

机构信息

Institute of Pharmaceutical Chemistry, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary.

MTA-SZTE Stereochemistry Research Group, Hungarian Academy of Sciences, Eötvös u. 6, H-6720 Szeged, Hungary.

出版信息

Molecules. 2016 Mar 7;21(3):318. doi: 10.3390/molecules21030318.

DOI:10.3390/molecules21030318
PMID:26959006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6273355/
Abstract

Flow chemistry-based syntheses of deuterium-labeled analogs of important antidiabetic chalcones were achieved via highly controlled partial C≡C bond deuteration of the corresponding 1,3-diphenylalkynones. The benefits of a scalable continuous process in combination with on-demand electrolytic D2 gas generation were exploited to suppress undesired over-reactions and to maximize reaction rates simultaneously. The novel deuterium-containing chalcone derivatives may have interesting biological effects and improved metabolic properties as compared with the parent compounds.

摘要

通过对相应的1,3-二苯基炔酮进行高度可控的部分C≡C键氘代反应,实现了基于流动化学的重要抗糖尿病查耳酮氘代类似物的合成。利用可扩展连续过程与按需电解产生D2气体相结合的优势,抑制了不期望的过度反应并同时最大化反应速率。与母体化合物相比,新型含氘查耳酮衍生物可能具有有趣的生物学效应和改善的代谢特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/c8f43803a7be/molecules-21-00318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/903555670340/molecules-21-00318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/6e521efd2734/molecules-21-00318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/11fade562d11/molecules-21-00318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/af30d25925c6/molecules-21-00318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/c8f43803a7be/molecules-21-00318-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/903555670340/molecules-21-00318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/6e521efd2734/molecules-21-00318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/11fade562d11/molecules-21-00318-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/af30d25925c6/molecules-21-00318-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea7/6273355/c8f43803a7be/molecules-21-00318-g005.jpg

相似文献

1
Continuous-Flow Synthesis of Deuterium-Labeled Antidiabetic Chalcones: Studies towards the Selective Deuteration of the Alkynone Core.氘标记抗糖尿病查耳酮的连续流合成:炔酮核心选择性氘代的研究
Molecules. 2016 Mar 7;21(3):318. doi: 10.3390/molecules21030318.
2
Highly Selective Continuous-Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives.潜在生物活性氘代查尔酮衍生物的高选择性连续流合成
Chempluschem. 2015 May;80(5):859-864. doi: 10.1002/cplu.201402426. Epub 2015 Feb 23.
3
Highly selective deuteration of pharmaceutically relevant nitrogen-containing heterocycles: a flow chemistry approach.高选择性氘代药物相关含氮杂环:一种流动化学方法。
Mol Divers. 2011 Aug;15(3):605-11. doi: 10.1007/s11030-010-9276-z. Epub 2010 Sep 15.
4
Design, Synthesis, Characterization and in vivo Antidiabetic Activity Evaluation of Some Chalcone Derivatives.设计、合成、表征及某些查尔酮衍生物的体内抗糖尿病活性评价。
Drug Des Devel Ther. 2021 Jul 17;15:3119-3129. doi: 10.2147/DDDT.S316185. eCollection 2021.
5
Design, synthesis chalcone derivatives as AdipoR agonist for type 2 diabetes.设计、合成查尔酮衍生物作为治疗 2 型糖尿病的 AdipoR 激动剂。
Chem Biol Drug Des. 2018 Aug;92(2):1525-1536. doi: 10.1111/cbdd.13319. Epub 2018 May 30.
6
[Exhaustive Syntheses of Deuterium-labelled Compounds].[氘标记化合物的详尽合成]
Yakugaku Zasshi. 2022;142(2):139-144. doi: 10.1248/yakushi.21-00173-2.
7
Synthetic studies towards the mulberry Diels-Alder adducts: H-bond accelerated cycloadditions of chalcones.桑树 Diels-Alder 加合物的合成研究:查尔酮的氢键加速环加成反应。
Org Biomol Chem. 2012 Aug 14;10(30):6010-21. doi: 10.1039/c2ob25115a. Epub 2012 Apr 10.
8
Synthesis of deuterium-labeled crizotinib, a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).氘标记的克唑替尼的合成,克唑替尼是一种强效且选择性的间充质上皮转化因子(c-MET)激酶和间变性淋巴瘤激酶(ALK)双重抑制剂。
J Labelled Comp Radiopharm. 2018 Dec;61(14):1036-1042. doi: 10.1002/jlcr.3678. Epub 2018 Sep 9.
9
An efficient and facile synthesis of deuterium-labeled anticancer agent bendamustine hydrochloride.一种高效简便的氘代抗癌药物盐酸苯达莫司汀的合成方法。
J Labelled Comp Radiopharm. 2018 Sep;61(11):869-874. doi: 10.1002/jlcr.3637. Epub 2018 May 28.
10
Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds--synthesis and in vitro metabolism of deuterated derivatives of dronedadrone.氘代对某些药理活性化合物代谢和清除的影响——决奈达隆氘代衍生物的合成与体外代谢
J Labelled Comp Radiopharm. 2013 Jul-Aug;56(9-10):504-12. doi: 10.1002/jlcr.3090. Epub 2013 Sep 4.

引用本文的文献

1
Unlocking the potential of hydrogen deuterium exchange via an iterative continuous-flow deuteration process.通过迭代连续流氘化过程释放氢氘交换的潜力。
Nat Commun. 2025 Feb 3;16(1):1314. doi: 10.1038/s41467-025-56600-8.
2
Significance of Chalcone Scaffolds in Medicinal Chemistry.查尔酮骨架在药物化学中的意义。
Top Curr Chem (Cham). 2024 Jun 27;382(3):22. doi: 10.1007/s41061-024-00468-7.
3
An Insight into Synthetic Strategies, SAR Study and Anticancer Mechanism of Chalcone Derivatives: Medicinal Chemistry Perspective.

本文引用的文献

1
Highly Selective Continuous-Flow Synthesis of Potentially Bioactive Deuterated Chalcone Derivatives.潜在生物活性氘代查尔酮衍生物的高选择性连续流合成
Chempluschem. 2015 May;80(5):859-864. doi: 10.1002/cplu.201402426. Epub 2015 Feb 23.
2
A Randomized Phase I Evaluation of CTP-499, a Novel Deuterium-Containing Drug Candidate for Diabetic Nephropathy.CTP-499,一种用于治疗糖尿病肾病的含氘新药候选物的随机 I 期评估。
Clin Pharmacol Drug Dev. 2013 Jan;2(1):53-66. doi: 10.1002/cpdd.3. Epub 2013 Feb 21.
3
Strategic Application of Residence-Time Control in Continuous-Flow Reactors.
查尔酮衍生物的合成策略、构效关系研究及抗癌机制洞察:药物化学视角
Curr Drug Res Rev. 2025;17(2):237-253. doi: 10.2174/0125899775278752240115110806.
4
Synthesis of Chalcones Derivatives and Their Biological Activities: A Review.查尔酮衍生物的合成及其生物活性:综述
ACS Omega. 2022 Aug 2;7(32):27769-27786. doi: 10.1021/acsomega.2c01779. eCollection 2022 Aug 16.
5
Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1'--isopropyl ether Shows Improved Selectivity Against the Epstein-Barr Virus Lytic Cycle.低细胞毒性原黄酮类化合物作为抗病毒药物:原阿片因 1'--异丙醚对 EBV 裂解周期显示出改善的选择性。
Int J Mol Sci. 2019 Dec 12;20(24):6269. doi: 10.3390/ijms20246269.
6
Chalcone Derivatives: Promising Starting Points for Drug Design.查尔酮衍生物:药物设计的理想起始点
Molecules. 2017 Jul 25;22(8):1210. doi: 10.3390/molecules22081210.
连续流反应器中停留时间控制的策略应用。
ChemistryOpen. 2015 Jun;4(3):212-23. doi: 10.1002/open.201500018. Epub 2015 May 20.
4
Therapeutic Challenges in Diabetes Prevention: We Have Not Found the "Exercise Pill".糖尿病预防中的治疗挑战:我们尚未找到“运动药丸”。
Clin Pharmacol Ther. 2015 Aug;98(2):162-9. doi: 10.1002/cpt.146. Epub 2015 Jun 25.
5
Prevention of gestational diabetes mellitus: Where are we now?妊娠期糖尿病的预防:我们目前的进展如何?
Diabetes Obes Metab. 2015 Sep;17(9):824-34. doi: 10.1111/dom.12495. Epub 2015 Jul 1.
6
The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future.当前糖尿病的药物治疗现状与未来展望。
Clin Pharmacol Ther. 2015 Aug;98(2):170-84. doi: 10.1002/cpt.144. Epub 2015 Jun 23.
7
The Economic Costs of Type 2 Diabetes: A Global Systematic Review.2型糖尿病的经济成本:一项全球系统评价
Pharmacoeconomics. 2015 Aug;33(8):811-31. doi: 10.1007/s40273-015-0268-9.
8
Organic synthesis: march of the machines.有机合成:机器的前进。
Angew Chem Int Ed Engl. 2015 Mar 9;54(11):3449-64. doi: 10.1002/anie.201410744. Epub 2015 Jan 13.
9
Application of a deuterium replacement strategy to modulate the pharmacokinetics of 7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-3-(4-methoxy-2-methylphenyl)-2,6-dimethylpyrazolo[5,1-b]oxazole, a novel CRF1 antagonist.氘取代策略在调节新型促肾上腺皮质激素释放因子1(CRF1)拮抗剂7-(3,5-二甲基-1H-1,2,4-三唑-1-基)-3-(4-甲氧基-2-甲基苯基)-2,6-二甲基吡唑并[5,1-b]恶唑的药代动力学中的应用
Drug Metab Dispos. 2014 May;42(5):954-62. doi: 10.1124/dmd.114.057265. Epub 2014 Mar 10.
10
Using deuterium in drug discovery: leaving the label in the drug.在药物发现中使用氘:让药物带上标签。
J Med Chem. 2014 May 8;57(9):3595-611. doi: 10.1021/jm4007998. Epub 2013 Dec 2.